Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by David Paling
Phenytoin for Neuroprotection in Patients With Acute Optic Neuritis: A Randomised, Placebo-Controlled, Phase 2 Trial
The Lancet Neurology
Neurology
Is a Wearable Sensor-Based Characterisation of Gait Robust Enough to Overcome Differences Between Measurement Protocols? A Multi-Centric Pragmatic Study in Patients With Multiple Sclerosis
Sensors
Instrumentation
Information Systems
Electronic Engineering
Biochemistry
Analytical Chemistry
Molecular Physics,
Electrical
Atomic
Medicine
Optics
Related publications
Safety and Efficacy of Opicinumab in Acute Optic Neuritis (RENEW): A Randomised, Placebo-Controlled, Phase 2 Trial
The Lancet Neurology
Neurology
Oral Lipoic Acid as a Treatment for Acute Optic Neuritis: A Blinded, Placebo Controlled Randomized Trial
Multiple Sclerosis Journal - Experimental, Translational and Clinical
Olaparib Combined With Abiraterone in Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial
The Lancet Oncology
Oncology
Noninvasive Ventilation for Acute Respiratory Failure: A Prospective Randomised Placebo-Controlled Trial
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
OP0130 Mepolizumab for the Treatment of Patients With Eosinophilic Granulomatosis With Polyangiitis: A Phase Iii Randomised, Placebo-Controlled Trial
Fingolimod After a First Unilateral Episode of Acute Optic Neuritis (MOVING) – Preliminary Results From a Randomized, Rater-Blind, Active-Controlled, Phase 2 Trial
BMC Neurology
Medicine
Neurology
CONFIRM: A Double-Blind, Placebo-Controlled Phase III Clinical Trial Investigating the Effect of Nivolumab in Patients With Relapsed Mesothelioma: Study Protocol for a Randomised Controlled Trial
Trials
Medicine
Pharmacology
Information Sheets for Patients With Acute Chest Pain: Randomised Controlled Trial
BMJ
A Phase 1b Randomized, Placebo-Controlled Clinical Trial With SNF472 in Hemodialysis Patients
British Journal of Clinical Pharmacology
Pharmacology
